Advertisement
Screener

EMERGENT BIOSOLUTIONS INC. (EBS) Increase (Decrease) in Inventories

2.8 / 5 stars · 68/120 Roast Me

EMERGENT BIOSOLUTIONS INC. Increase (Decrease) in Inventories

EMERGENT BIOSOLUTIONS INC. (EBS) reported Increase (Decrease) in Inventories of -$39.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-06

  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was -$24.00M, a 197.17% decline year-over-year.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was -$15.80M, a 818.18% decline year-over-year.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$14.20M.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was $17.60M, a 2.22% decline year-over-year.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in inventories for fiscal 2025 was $30.30M, a 23.67% increase from fiscal 2024.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in inventories for fiscal 2024 was $24.50M.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in inventories for fiscal 2023 was -$600.00K, a 101.05% decline from fiscal 2022.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in inventories for fiscal 2022 was $57.10M, a 14.26% decline from fiscal 2021.
Period endIncrease (Decrease) in Inventories 3 monthIncrease (Decrease) in Inventories 3 month as first filedIncrease (Decrease) in Inventories 6 monthIncrease (Decrease) in Inventories 6 month as first filedIncrease (Decrease) in Inventories 9 monthIncrease (Decrease) in Inventories 9 month as first filedIncrease (Decrease) in Inventories 12 monthIncrease (Decrease) in Inventories 12 month as first filed
2026-06-30-$24.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$39.80M
10-Q · filed 2026-08-06
-$54.00M
derived: sum of 3 quarters · filed 2026-08-06
-$36.40M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$15.80M
10-Q · filed 2026-05-01
-$30.00M
derived: sum of 2 quarters · filed 2026-05-01
-$12.40M
derived: sum of 3 quarters · filed 2026-05-01
$12.30M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$14.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$3.40M
derived: sum of 2 quarters · filed 2026-02-27
$28.10M
derived: sum of 3 quarters · filed 2026-08-06
$30.30M
10-K · filed 2026-02-27
2025-09-30$17.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
$42.30M
derived: sum of 2 quarters · filed 2026-08-06
$44.50M
10-Q · filed 2025-10-30
$33.50M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$24.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$26.90M
10-Q · filed 2026-08-06
$15.90M
derived: sum of 3 quarters · filed 2026-08-06
$33.90M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$2.20M
10-Q · filed 2026-05-01
-$8.80M
derived: sum of 2 quarters · filed 2026-05-01
$9.20M
derived: sum of 3 quarters · filed 2026-05-01
$22.20M
derived: sum of 4 quarters · filed 2026-05-01
2024-12-31-$11.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$7.00M
derived: sum of 2 quarters · filed 2026-02-27
$20.00M
derived: sum of 3 quarters · filed 2026-02-27
$24.50M
10-K · filed 2026-02-27
2024-09-30$18.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
$31.00M
derived: sum of 2 quarters · filed 2025-10-30
$35.50M
10-Q · filed 2025-10-30
$9.90M
derived: sum of 4 quarters · filed 2026-02-27
2024-06-30$13.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$17.50M
10-Q · filed 2025-08-07
-$8.10M
derived: sum of 3 quarters · filed 2026-02-27
-$8.00M
derived: sum of 4 quarters · filed 2026-02-27
2024-03-31$4.50M
10-Q · filed 2025-05-08
-$21.10M
derived: sum of 2 quarters · filed 2026-02-27
-$21.00M
derived: sum of 3 quarters · filed 2026-02-27
-$26.80M
derived: sum of 4 quarters · filed 2026-02-27
2023-12-31-$25.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$25.50M
derived: sum of 2 quarters · filed 2026-02-27
-$31.30M
derived: sum of 3 quarters · filed 2026-02-27
-$600.00K
10-K · filed 2026-02-27
2023-09-30$100.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
-$5.70M
derived: sum of 2 quarters · filed 2024-11-07
$25.00M
10-Q · filed 2024-11-07
-$20.70M
derived: sum of 4 quarters · filed 2025-03-04
2023-06-30-$5.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
$24.90M
10-Q · filed 2024-08-07
$23.80M
10-Q · filed 2023-08-09
-$20.80M
derived: sum of 3 quarters · filed 2025-03-04
$6.50M
derived: sum of 4 quarters · filed 2025-03-04
2023-03-31$30.70M
10-Q · filed 2024-05-02
$29.60M
10-Q · filed 2023-05-10
-$15.00M
derived: sum of 2 quarters · filed 2025-03-04
$12.30M
derived: sum of 3 quarters · filed 2025-03-04
$37.70M
derived: sum of 4 quarters · filed 2025-03-04
2022-12-31-$45.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04
-$18.40M
derived: sum of 2 quarters · filed 2025-03-04
$7.00M
derived: sum of 3 quarters · filed 2025-03-04
$57.10M
10-K · filed 2025-03-04
$51.90M
10-K · filed 2023-03-01
2022-09-30$27.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-12-11
$52.70M
derived: sum of 2 quarters · filed 2023-12-11
$102.80M
10-Q · filed 2023-12-11
$112.20M
10-Q · filed 2022-11-09
$111.40M
derived: sum of 4 quarters · filed 2024-03-08
2022-06-30$25.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$75.50M
10-Q · filed 2023-08-09
$84.10M
derived: sum of 3 quarters · filed 2024-03-08
$62.40M
derived: sum of 4 quarters · filed 2024-03-08
2022-03-31$50.10M
10-Q · filed 2023-05-10
$58.70M
derived: sum of 2 quarters · filed 2024-03-08
$37.00M
derived: sum of 3 quarters · filed 2024-03-08
$16.80M
derived: sum of 4 quarters · filed 2024-03-08
2021-12-31$8.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08
-$13.10M
derived: sum of 2 quarters · filed 2024-03-08
-$33.30M
derived: sum of 3 quarters · filed 2024-03-08
$66.60M
10-K · filed 2024-03-08
$44.00M
10-K · filed 2022-02-25
2021-09-30-$21.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
-$41.90M
derived: sum of 2 quarters · filed 2022-11-09
$58.00M
10-Q · filed 2022-11-09
$77.30M
derived: sum of 4 quarters · filed 2023-12-11
2021-06-30-$20.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02
$79.70M
10-Q · filed 2022-08-02
$99.00M
derived: sum of 3 quarters · filed 2023-12-11
$132.90M
derived: sum of 4 quarters · filed 2023-12-11
2021-03-31$99.90M
10-Q · filed 2022-04-29
$119.20M
derived: sum of 2 quarters · filed 2023-12-11
$153.10M
derived: sum of 3 quarters · filed 2023-12-11
$141.20M
derived: sum of 4 quarters · filed 2023-12-11
2020-12-31$19.30M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-12-11
$53.20M
derived: sum of 2 quarters · filed 2023-12-11
$41.30M
derived: sum of 3 quarters · filed 2023-12-11
$66.90M
10-K/A · filed 2023-12-11
$83.20M
10-K · filed 2021-02-19
2020-09-30$33.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
$22.00M
derived: sum of 2 quarters · filed 2021-11-05
$47.60M
10-Q · filed 2021-11-05
$39.90M
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30-$11.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30
$13.70M
10-Q · filed 2021-07-30
$6.00M
derived: sum of 3 quarters · filed 2022-02-25
$4.30M
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31$25.60M
10-Q · filed 2021-04-30
$17.90M
derived: sum of 2 quarters · filed 2022-02-25
$16.20M
derived: sum of 3 quarters · filed 2022-02-25
$37.10M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31-$7.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
-$9.40M
derived: sum of 2 quarters · filed 2022-02-25
$11.50M
derived: sum of 3 quarters · filed 2022-02-25
$16.70M
10-K · filed 2022-02-25
2019-09-30-$1.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$19.20M
derived: sum of 2 quarters · filed 2020-11-06
$24.40M
10-Q · filed 2020-11-06
$43.40M
derived: sum of 4 quarters · filed 2021-02-19
2019-06-30$20.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31
$26.10M
10-Q · filed 2020-07-31
$45.10M
derived: sum of 3 quarters · filed 2021-02-19
$31.40M
derived: sum of 4 quarters · filed 2021-02-19
2019-03-31$5.20M
10-Q · filed 2020-05-01
$24.20M
derived: sum of 2 quarters · filed 2021-02-19
$10.50M
derived: sum of 3 quarters · filed 2021-02-19
-$5.30M
derived: sum of 4 quarters · filed 2021-02-19
2018-12-31$19.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19
$5.30M
derived: sum of 2 quarters · filed 2021-02-19
-$10.50M
derived: sum of 3 quarters · filed 2021-02-19
$1.90M
10-K · filed 2021-02-19
2018-09-30-$13.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
-$29.50M
derived: sum of 2 quarters · filed 2019-11-07
-$17.10M
10-Q · filed 2019-11-07
-$17.07M
10-Q · filed 2018-11-02
-$18.09M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30-$15.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02
-$3.40M
10-Q · filed 2019-08-02
-$3.44M
10-Q · filed 2018-08-03
-$4.39M
derived: sum of 3 quarters · filed 2020-02-25
-$6.03M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31$12.40M
10-Q · filed 2019-05-08
$12.38M
10-Q · filed 2018-05-04
$11.41M
derived: sum of 2 quarters · filed 2020-02-25
$9.77M
derived: sum of 3 quarters · filed 2020-02-25
$9.57M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31-$987.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
-$2.63M
derived: sum of 2 quarters · filed 2020-02-25
-$2.83M
derived: sum of 3 quarters · filed 2020-02-25
-$6.10M
10-K · filed 2020-02-25
-$6.07M
10-K · filed 2018-02-23
2017-09-30-$1.64M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02
-$1.84M
derived: sum of 2 quarters · filed 2018-11-02
-$5.11M
10-Q · filed 2018-11-02
-$12.30M
derived: sum of 4 quarters · filed 2019-02-22
2017-06-30-$203.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03
-$3.47M
10-Q · filed 2018-08-03
-$10.66M
derived: sum of 3 quarters · filed 2019-02-22
-$14.21M
derived: sum of 4 quarters · filed 2019-02-22
2017-03-31-$3.27M
10-Q · filed 2018-05-04
$3.27M
10-Q · filed 2017-05-05
-$10.45M
derived: sum of 2 quarters · filed 2019-02-22
-$14.01M
derived: sum of 3 quarters · filed 2019-02-22
$16.99M
derived: sum of 4 quarters · filed 2019-02-22
2016-12-31-$7.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22
-$10.74M
derived: sum of 2 quarters · filed 2019-02-22
$20.26M
derived: sum of 3 quarters · filed 2019-02-22
$9.00M
10-K · filed 2019-02-22
$9.03M
10-K · filed 2017-02-28
2016-09-30-$3.56M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03
$27.45M
derived: sum of 2 quarters · filed 2017-11-03
$16.18M
10-Q · filed 2017-11-03
-$16.18M
10-Q · filed 2016-11-09
$41.84M
derived: sum of 4 quarters · filed 2018-02-23
2016-06-30$31.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04
$19.74M
10-Q · filed 2017-08-04
$45.40M
derived: sum of 3 quarters · filed 2018-02-23
$11.97M
derived: sum of 4 quarters · filed 2018-02-23
2016-03-31-$11.26M
10-Q · filed 2017-05-05
$11.26M
10-Q · filed 2016-05-06
$14.39M
derived: sum of 2 quarters · filed 2018-02-23
-$19.04M
derived: sum of 3 quarters · filed 2018-02-23
-$16.46M
derived: sum of 4 quarters · filed 2018-02-23
2015-12-31$25.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23
-$7.77M
derived: sum of 2 quarters · filed 2018-02-23
-$5.20M
derived: sum of 3 quarters · filed 2018-02-23
$11.26M
10-K · filed 2018-02-23
2015-09-30-$33.43M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
-$30.86M
derived: sum of 2 quarters · filed 2016-11-09
-$14.40M
10-Q · filed 2016-11-09
$14.40M
10-Q · filed 2015-11-06
-$13.90M
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30$2.57M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05
$19.03M
10-Q · filed 2016-08-05
$19.53M
derived: sum of 3 quarters · filed 2017-02-28
$16.04M
derived: sum of 4 quarters · filed 2017-02-28
2015-03-31$16.46M
10-Q · filed 2016-05-06
$16.96M
derived: sum of 2 quarters · filed 2017-02-28
$13.46M
derived: sum of 3 quarters · filed 2017-02-28
$8.22M
derived: sum of 4 quarters · filed 2017-02-28
2014-12-31$500.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
-$3.00M
derived: sum of 2 quarters · filed 2017-02-28
-$8.23M
derived: sum of 3 quarters · filed 2017-02-28
-$4.23M
10-K · filed 2017-02-28
2014-09-30-$3.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06
-$8.73M
derived: sum of 2 quarters · filed 2015-11-06
-$4.73M
10-Q · filed 2015-11-06
-$6.41M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30-$5.24M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
-$1.23M
10-Q · filed 2015-08-06
-$2.91M
derived: sum of 3 quarters · filed 2016-02-29
-$5.17M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31$4.01M
10-Q · filed 2015-05-08
$2.32M
derived: sum of 2 quarters · filed 2016-02-29
$67.00K
derived: sum of 3 quarters · filed 2016-02-29
-$3.50M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31-$1.68M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
-$3.94M
derived: sum of 2 quarters · filed 2016-02-29
-$7.50M
derived: sum of 3 quarters · filed 2016-02-29
-$518.00K
10-K · filed 2016-02-29
2013-09-30-$2.26M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
-$5.82M
derived: sum of 2 quarters · filed 2014-11-10
$1.16M
10-Q · filed 2014-11-10
-$1.92M
derived: sum of 4 quarters · filed 2015-03-09
2013-06-30-$3.57M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08
$3.42M
10-Q · filed 2014-08-08
$337.00K
derived: sum of 3 quarters · filed 2015-03-09
$2.57M
derived: sum of 4 quarters · filed 2015-03-09
2013-03-31$6.99M
10-Q · filed 2014-05-12
$3.90M
derived: sum of 2 quarters · filed 2015-03-09
$6.14M
derived: sum of 3 quarters · filed 2015-03-09
$4.83M
derived: sum of 4 quarters · filed 2015-03-09
2012-12-31-$3.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09
-$847.00K
derived: sum of 2 quarters · filed 2015-03-09
-$2.16M
derived: sum of 3 quarters · filed 2015-03-09
$500.00K
10-K · filed 2015-03-09
2012-09-30$2.24M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
$926.00K
derived: sum of 2 quarters · filed 2013-11-08
$3.58M
10-Q · filed 2013-11-08
$266.00K
derived: sum of 4 quarters · filed 2014-03-10
2012-06-30-$1.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06
$1.35M
10-Q · filed 2013-08-06
-$1.97M
derived: sum of 3 quarters · filed 2014-03-10
-$1.25M
derived: sum of 4 quarters · filed 2014-03-10
2012-03-31$2.66M
10-Q · filed 2013-05-03
-$660.00K
derived: sum of 2 quarters · filed 2014-03-10
$57.00K
derived: sum of 3 quarters · filed 2014-03-10
-$4.84M
derived: sum of 4 quarters · filed 2014-03-10
2011-12-31-$3.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10
-$2.60M
derived: sum of 2 quarters · filed 2014-03-10
-$7.50M
derived: sum of 3 quarters · filed 2014-03-10
$1.94M
10-K · filed 2014-03-10
2011-09-30$717.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01
-$4.18M
derived: sum of 2 quarters · filed 2012-11-01
$5.26M
10-Q · filed 2012-11-01
-$5.26M
10-Q · filed 2011-11-04
$8.26M
derived: sum of 4 quarters · filed 2013-03-08
2011-06-30-$4.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03
$4.54M
10-Q · filed 2012-08-03
-$4.54M
10-Q · filed 2011-08-05
$7.54M
derived: sum of 3 quarters · filed 2013-03-08
$7.34M
derived: sum of 4 quarters · filed 2013-03-08
2011-03-31$9.44M
10-Q · filed 2012-05-04
$12.44M
derived: sum of 2 quarters · filed 2013-03-08
$12.24M
derived: sum of 3 quarters · filed 2013-03-08
2010-12-31$3.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08
$2.80M
derived: sum of 2 quarters · filed 2013-03-08
-$799.00K
10-K · filed 2013-03-08
2010-09-30-$204.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04
-$3.80M
10-Q · filed 2011-11-04
2010-06-30-$3.60M
10-Q · filed 2011-08-05
2009-12-31-$6.21M
10-K · filed 2012-03-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
Vogenx, Inc. (VOGX)United States$0.355B
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Rezolute, Inc. (RZLT)United States$0.382B-6.45